Rapid and slow release phenytoin in epileptic patients at steady state: Comparative plasma levels and toxicity
- 1 August 1982
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 10 (4) , 365-382
- https://doi.org/10.1007/bf01065169
Abstract
Phenytoin plasma level and toxicity data were compared in a three-way crossover study performed in 18 patients at steady state. Formulations compared were a rapid and a slow release capsule and an oral solution. Plasma concentration-time integrals and maximum plasma phenytoin levels were significantly greater for the rapid release capsule and solution than for the slow release capsule. The incidence of nystagmus and toxicity did not differ for the three treatments,but the occurrence of mental symptoms was more frequent for the oral solution, possibly because of the solvent used in this formulation.This publication has 5 references indexed in Scilit:
- Liquid-chromatographic method for simultaneous determination of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in plasma and urine.Clinical Chemistry, 1980
- LIQUID-CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS DETERMINATION OF PHENYTOIN AND 5-(4-HYDROXYPHENYL)-5-PHENYLHYDANTOIN IN PLASMA AND URINE1980
- Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: Consequences for phenytoin therapyJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Rate of phenytoin accumulation in man: A simulation studyJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978